We've found
					184,457 				
					clinical trials				
				
			
		
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling
  
							
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	Afatinib Expanded Access Program
		Status: Enrolling	
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling
  
							
  	
	Chronic Myeloid Leukemia Clinical Trial
	Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	
	
			Updated: 9/26/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Aneurysm, Abdominal Clinical Trial
	Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study
		Status: Enrolling
  
							
  	
	Aortic Aneurysm, Abdominal Clinical Trial
	Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Malignant Brain Tumors Clinical Trial
	PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors
		Status: Enrolling
  
							
  	
	Malignant Brain Tumors Clinical Trial
	PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors
		Status: Enrolling	
	
	
			Updated: 2/6/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Dermatitis, Atopic Clinical Trial
	Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
		Status: Enrolling
  
							
  	
	Dermatitis, Atopic Clinical Trial
	Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
		Status: Enrolling	
	
	
			Updated: 7/26/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Psychiatry / Psychology Clinical Trial
	Evaluating a Novel Method of Generalizing Emotion Regulation
		Status: Enrolling
  
							
  	
	Psychiatry / Psychology Clinical Trial
	Evaluating a Novel Method of Generalizing Emotion Regulation
		Status: Enrolling	
	
	
			Updated: 8/6/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 CONGESTIVE HEART FAILURE Clinical Trial
	A Trial of a CPR Video in Heart Failure Patients
		Status: Enrolling
  
							
  	
	CONGESTIVE HEART FAILURE Clinical Trial
	A Trial of a CPR Video in Heart Failure Patients
		Status: Enrolling	
	
	
			Updated: 7/30/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Aneurysm, Abdominal Clinical Trial
	Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms
		Status: Enrolling
  
							
  	
	Aortic Aneurysm, Abdominal Clinical Trial
	Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Treatment Resistant Depression Clinical Trial
	Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
		Status: Enrolling
  
							
  	
	Treatment Resistant Depression Clinical Trial
	Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
		Status: Enrolling	
	
	
			Updated: 7/13/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Treatment Resistant Depression Clinical Trial
	Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
		Status: Enrolling
  
							
  	
	Treatment Resistant Depression Clinical Trial
	Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
		Status: Enrolling	
	
	
			Updated: 7/13/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Study of LY3023414 in Participants With Advanced Cancer
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Oncology Clinical Trial
	A Study of LY3023414 in Participants With Advanced Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cerebral Aneurysm Clinical Trial
	Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Infusion Reactions Clinical Trial
	Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Genetic Determinants of Congenital Heart Disease Outcomes
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Genetic Determinants of Congenital Heart Disease Outcomes
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Foot Ulcer Clinical Trial
	Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
		Status: Enrolling
  
							
  	
	Diabetic Foot Ulcer Clinical Trial
	Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
		Status: Enrolling	
	
	
			Updated: 9/14/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Retroperitoneal Sarcoma Clinical Trial
	Proton or Photon RT for Retroperitoneal Sarcomas
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Retroperitoneal Sarcoma Clinical Trial
	Proton or Photon RT for Retroperitoneal Sarcomas
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Retroperitoneal Sarcoma Clinical Trial
	Proton or Photon RT for Retroperitoneal Sarcomas
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Retroperitoneal Sarcoma Clinical Trial
	Proton or Photon RT for Retroperitoneal Sarcomas
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
		Status: Enrolling,
							Phase
  
							
  	
	Oncology Clinical Trial
	Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/1/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Substance Use Clinical Trial
	Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
		Status: Enrolling,
							Phase
  
							
  	
	Substance Use Clinical Trial
	Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 6/24/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Other, Reproductive Clinical Trial
	Effect of Testosterone Treatment on Embryo Quality
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Other, Reproductive Clinical Trial
	Effect of Testosterone Treatment on Embryo Quality
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Migraine Disorders Clinical Trial
	A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Migraine Disorders Clinical Trial
	A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 5/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Migraine Disorders Clinical Trial
	A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Migraine Disorders Clinical Trial
	A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 5/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Migraine Disorders Clinical Trial
	A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Migraine Disorders Clinical Trial
	A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 5/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling
  
							
  	
	Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	
	
			Updated: 10/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling
  
							
  	
	Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	
	
			Updated: 10/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling
  
							
  	
	Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	
	
			Updated: 10/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling
  
							
  	
	Other, Reproductive Clinical Trial
	Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	
	
			Updated: 10/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Plastic Bronchitis Clinical Trial
	International Plastic Bronchitis Registry
		Status: Enrolling,
							Phase
  
							
  	
	Plastic Bronchitis Clinical Trial
	International Plastic Bronchitis Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Non Small Cell Lung Cancer (NSCLC) Clinical Trial
	Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Non Small Cell Lung Cancer (NSCLC) Clinical Trial
	Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/9/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Non Small Cell Lung Cancer (NSCLC) Clinical Trial
	Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Non Small Cell Lung Cancer (NSCLC) Clinical Trial
	Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/9/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Osteoporosis Clinical Trial
	An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Osteoporosis Clinical Trial
	An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 9/21/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					184,457 
				
					clinical trials
				
				
				
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Non-Small-Cell Lung Clinical Trial
	
Updated: 11/29/2016
  
  
  Afatinib Expanded Access Program
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Chronic Myeloid Leukemia Clinical Trial
	
Updated: 9/26/2013
  
  
  Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
		Status: Enrolling	
	Updated: 9/26/2013
Click here to add this to my saved trials
	    
	 
  	
	Aortic Aneurysm, Abdominal Clinical Trial
	
Updated: 12/31/1969
  
  
  Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Malignant Brain Tumors Clinical Trial
	
Updated: 2/6/2013
  
  
  PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors
		Status: Enrolling	
	Updated: 2/6/2013
Click here to add this to my saved trials
	    
	 
  	
	Dermatitis, Atopic Clinical Trial
	
Updated: 7/26/2012
  
  
  Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
		Status: Enrolling	
	Updated: 7/26/2012
Click here to add this to my saved trials
	    
	 
  	
	Psychiatry / Psychology Clinical Trial
	
Updated: 8/6/2015
  
  
  Evaluating a Novel Method of Generalizing Emotion Regulation
		Status: Enrolling	
	Updated: 8/6/2015
Click here to add this to my saved trials
	    
	 
  	
	CONGESTIVE HEART FAILURE Clinical Trial
	
Updated: 7/30/2012
  
  
  A Trial of a CPR Video in Heart Failure Patients
		Status: Enrolling	
	Updated: 7/30/2012
Click here to add this to my saved trials
	    
	 
  	
	Aortic Aneurysm, Abdominal Clinical Trial
	
Updated: 12/31/1969
  
  
  Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Treatment Resistant Depression Clinical Trial
	
Updated: 7/13/2015
  
  
  Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
	    
	 
  	
	Treatment Resistant Depression Clinical Trial
	
Updated: 7/13/2015
  
  
  Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
		Status: Enrolling	
	Updated: 7/13/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of LY3023414 in Participants With Advanced Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cerebral Aneurysm Clinical Trial
	
Updated: 12/31/1969
  
  
  Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cerebral Aneurysm Clinical Trial
	
Updated: 12/31/1969
  
  
  Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cerebral Aneurysm Clinical Trial
	
Updated: 12/31/1969
  
  
  Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cerebral Aneurysm Clinical Trial
	
Updated: 12/31/1969
  
  
  Framing Eighteen Coils in Cerebral Aneurysms Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Infusion Reactions Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Genetic Determinants of Congenital Heart Disease Outcomes
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Foot Ulcer Clinical Trial
	
Updated: 9/14/2012
  
  
  Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
		Status: Enrolling	
	Updated: 9/14/2012
Click here to add this to my saved trials
	    
	 
  	
	Retroperitoneal Sarcoma Clinical Trial
	
Updated: 12/31/1969
  
  
  Proton or Photon RT for Retroperitoneal Sarcomas
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Retroperitoneal Sarcoma Clinical Trial
	
Updated: 12/31/1969
  
  
  Proton or Photon RT for Retroperitoneal Sarcomas
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 5/1/2018
  
  
  Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/1/2018
Click here to add this to my saved trials
	    
	 
  	
	Substance Use Clinical Trial
	
Updated: 6/24/2013
  
  
  Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 6/24/2013
Click here to add this to my saved trials
	    
	 
  	
	Other, Reproductive Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Testosterone Treatment on Embryo Quality
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Migraine Disorders Clinical Trial
	
Updated: 5/4/2016
  
  
  A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 5/4/2016
Click here to add this to my saved trials
	    
	 
  	
	Migraine Disorders Clinical Trial
	
Updated: 5/4/2016
  
  
  A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 5/4/2016
Click here to add this to my saved trials
	    
	 
  	
	Migraine Disorders Clinical Trial
	
Updated: 5/4/2016
  
  
  A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 5/4/2016
Click here to add this to my saved trials
	    
	 
  	
	Other, Reproductive Clinical Trial
	
Updated: 10/31/2012
  
  
  Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
	    
	 
  	
	Other, Reproductive Clinical Trial
	
Updated: 10/31/2012
  
  
  Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
	    
	 
  	
	Other, Reproductive Clinical Trial
	
Updated: 10/31/2012
  
  
  Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
	    
	 
  	
	Other, Reproductive Clinical Trial
	
Updated: 10/31/2012
  
  
  Comparison of Aneuploidy Risk Evaluations
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
	    
	 
  	
	Plastic Bronchitis Clinical Trial
	
Updated: 12/31/1969
  
  
  International Plastic Bronchitis Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Non Small Cell Lung Cancer (NSCLC) Clinical Trial
	
Updated: 12/9/2013
  
  
  Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/9/2013
Click here to add this to my saved trials
	    
	 
  	
	Non Small Cell Lung Cancer (NSCLC) Clinical Trial
	
Updated: 12/9/2013
  
  
  Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/9/2013
Click here to add this to my saved trials
	    
	 
  	
	Osteoporosis Clinical Trial
	
Updated: 9/21/2015
  
  
  An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 9/21/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	